FTRE NASDAQ
Fortrea Holdings Inc.
1W: +0.6%
1M: +8.9%
3M: +12.0%
YTD: +19.0%
1Y: +110.1%
3Y: -31.7%
$20.00
+0.60 (+3.09%)
Weekly Expected Move ±8.6%
$17
$18
$20
$22
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (100)
Fortrea Holdings Inc. (NASDAQ:FTRE) Stock Rated “Hold” by Sell-Side Brokerages
VIRGINIA RETIREMENT SYSTEMS ET Al Purchases New Position in Fortrea Holdings Inc. $FTRE
Fortrea (NASDAQ:FTRE) Shares Up 3.6% - Here's Why - MarketBeat
Fortrea Holdings (FTRE) Reinstates Its CFO, Is The Stock A Bargain? - simplywall.st
Trading the Move, Not the Narrative: (FTRE) Edition - Stock Traders Daily
Fortrea Holdings (FTRE) grants its CFO 144,434 stock units vesting over three years - Stock Titan
Tax-related Fortrea (FTRE) stock sale adds to ex-officer’s recent trades - Stock Titan
Fortrea Holdings Inc. (FTRE) ex-officer plans stock sale tied to tax on vested award - Stock Titan
Is CFO Return Altering The Investment Case For Fortrea Holdings Stock (FTRE)? - simplywall.st
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
New CFO receives stock awards as Fortrea hires five employees - Stock Titan
Fortrea (FTRE) COO sells shares in mandatory tax trade - Stock Titan
Stock sale by former Fortrea (FTRE) officer includes shares to cover taxes - Stock Titan
Fortrea to Participate in September Investor Conferences
WINTON GROUP Ltd Buys 82,059 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea Holdings (NASDAQ: FTRE) officer plans Rule 144 stock sale to cover taxes - Stock Titan
Former Fortrea (FTRE) officer plans stock sale partly to cover taxes - Stock Titan
Tax-covering stock sale planned at Fortrea (FTRE) - Stock Titan
Stocks making big moves this week: SAIC, Reddit, Fortrea, GitLab, and G-III
Fortrea acquiert l’unité de pharmacologie clinique et les activités de laboratoire bioanalytique de Worldwide Clinical Trials
Fortrea übernimmt Einheit für klinische Pharmakologie und bioanalytische Laboraktivitäten von Worldwide Clinical Trials
Fortrea เข้าซื้อกิจการหน่วยเภสัชวิทยาคลินิกและการปฏิบัติการห้องปฏิบัติการวิเคราะห์ทางชีวภาพจาก Worldwide Clinical Trials
Fortrea adquirirá de Worldwide Clinical Trials las operaciones de la Unidad de Farmacología Clínica y del Laboratorio de Bioanálisis
Fortrea Adquire Unidade de Farmacologia Clínica e Operações de Laboratório Bioanalítico da Worldwide Clinical Trials
Fortrea Akan Mengambil Alih Unit Farmakologi Klinikal dan Operasi Makmal Bioanalisis daripada Worldwide Clinical Trials
Fortrea, Worldwide Clinical Trials의 임상약리 유닛·생물분석 연구소 사업 인수
フォートリア、ワールドワイド・クリニカル・トライアルズから臨床薬理部門およびバイオアナリシスラボ事業を買収
Fortrea Akan Mengakuisisi Unit Farmakologi Klinis dan Operasional Laboratorium Bionalitik dari Worldwide Clinical Trials
Fortrea תרכוש את היחידה לפרמקולוגיה קלינית ואת פעילות המעבדה הביו-אנליטית של Worldwide Clinical Trials
Fortrea 將收購 Worldwide Clinical Trials 的臨床藥理學部門及生物分析實驗室業務
Fortrea 将收购 Worldwide Clinical Trials 的临床药理部门和生物分析实验室业务
Fortrea (FTRE) Stock Is Up, What You Need To Know
Fortrea (FTRE) Stock Is Up, What You Need To Know - Barchart.com
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
Fortrea (FTRE) Stock Is Up, What You Need To Know - StockStory
Fortrea (FTRE): Buy, Sell, or Hold Post Q2 Earnings?
Drug Development Inputs & Services Stocks Q2 In Review: Fortrea (NASDAQ:FTRE) Vs Peers
This Healthcare Services Stock Has 37% Upside
Fortrea (FTRE) Gains Traction in Turnaround
Fortrea Holdings (FTRE) Beat Expectations, Is The Upside Already Priced In?
Will Fortrea’s (FTRE) Higher 2026 Revenue Guidance and CFO Shift Recast Its Investment Narrative?
Dimensional Fund Advisors LP Increases Stake in Fortrea Holdings Inc. $FTRE
Fortrea (FTRE) Q2 2026 Earnings Call Transcript
Fortrea (FTRE) Q2 2026 Earnings Call Transcript
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last
Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last
Fifth Third Bancorp Has $267,000 Stake in Fortrea Holdings Inc. $FTRE
Fortrea Holdings Inc. (FTRE) Upgraded to Strong Buy: Here's What You Should Know
Fortrea Holdings Inc. (FTRE) Upgraded to Strong Buy: Here's What You Should Know
Fortrea Holdings Inc. (FTRE) Upgraded to Strong Buy: Here's What You Should Know
FTRE vs. ARGX: Which Stock Is the Better Value Option?
FTRE vs. ARGX: Which Stock Is the Better Value Option?
FTRE vs. ARGX: Which Stock Is the Better Value Option?
Best Momentum Stock to Buy for July 31st
Fortrea Holdings Inc. (FTRE) Is Attractively Priced Despite Fast-paced Momentum
Fortrea Holdings Inc. (FTRE) Surpasses Q2 Earnings and Revenue Estimates
Fortrea Reports Second Quarter 2026 Results
Fortrea Earnings: What To Look For From FTRE - Yahoo Finance
Quant snapshot: Bandwidth and Centene Corporation lead top-rated names as Bank of Marin Bancorp and Axos Financial Dynamics lag
Medpace leads a rally in CRO space after Q2 beat
3 Reasons to Sell FTRE and 1 Stock to Buy Instead - Yahoo Finance
Fortrea (FTRE) Stock Still Screens Cheap After Its 248% Run - Yahoo Finance
Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run?
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
Stocks Look Shaky, But This Sector is Booming (Biotech)
FTRE or ARGX: Which Is the Better Value Stock Right Now?
New Strong Buy Stocks for July 7th
Fortrea names Jason Knoblauch as CFO
Assessing Fortrea Holdings (FTRE) Valuation After A Strong Multi‑Month Share Price Rally - Yahoo Finance
Fortrea to Attend Jefferies Global Healthcare Conference
(FTRE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Analysts Are Bullish on These Healthcare Stocks: Fortrea Holdings Inc. (FTRE), Cullinan Management (CGEM) - The Globe and Mail
Spotting Winners: Fortrea (NASDAQ:FTRE) And Drug Development Inputs & Services Stocks In Q1
Spotting Winners: Fortrea (NASDAQ:FTRE) And Drug Development Inputs & Services Stocks In Q1 - Yahoo Finance
Fortrea Holdings Inc. (FTRE) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Fortrea (FTRE) Chief Accounting Officer sells 2,000 shares in open-market trade - Stock Titan
Fortrea (FTRE) director Peter Neupert settles 148,536 RSUs into common stock - Stock Titan
Fortrea’s Q1 Earnings Call: Our Top 5 Analyst Questions
Does Fortrea (FTRE) Shrinking Losses With Flat Sales Clarify Its Path to Sustainable Profitability?
Is Now An Opportune Moment To Examine Fortrea Holdings Inc. (NASDAQ:FTRE)?
Is Now An Opportune Moment To Examine Fortrea Holdings Inc. (NASDAQ:FTRE)? - Yahoo Finance
Does Fortrea (FTRE) Shrinking Losses With Flat Sales Clarify Its Path to Sustainable Profitability? - Yahoo Finance
Fortrea reiterates 2026 revenue of $2.55B-$2.65B amid $190M-$220M adjusted EBITDA target
Fortrea Q1 Earnings Call Highlights
12 Health Care Stocks Moving In Tuesday's Intraday Session
Fortrea Holdings Inc. Q1 2026 Earnings Call Summary
Fortrea Holdings Inc. Q1 2026 Earnings Call Summary
Fortrea (FTRE) Q1 2026 Earnings Transcript
Fortrea (FTRE) Q1 2026 Earnings Transcript
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
Earnings Scheduled For May 5, 2026
Fortrea’s (NASDAQ:FTRE) Q1 CY2026 Sales Beat Estimates, Stock Soars
Fortrea Holdings Non-GAAP EPS of $0.16 beats by $0.11, revenue of $636.5M beats by $10.56M
Fortrea Reports First Quarter 2026 Results
Fortrea Reports First Quarter 2026 Results